Cargando…
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
Background: The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Global Position Statement) recommended testosterone therapy for postmenopausal women with hypoactive sexual desire disorder (HSDD). Aim: To provide a clinical practice guideline for the use of testoster...
Autores principales: | Parish, Sharon J., Simon, James A., Davis, Susan R., Giraldi, Annamaria, Goldstein, Irwin, Goldstein, Sue W., Kim, Noel N., Kingsberg, Sheryl A., Morgentaler, Abraham, Nappi, Rossella E., Park, Kwangsung, Stuenkel, Cynthia A., Traish, Abdulmaged M., Vignozzi, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064950/ https://www.ncbi.nlm.nih.gov/pubmed/33797277 http://dx.doi.org/10.1089/jwh.2021.29037 |
Ejemplares similares
-
Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018) -
Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022) -
Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020) -
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019) -
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019)